03:36 PM EST, 11/19/2025 (MT Newswires) -- (Updates with Pfizer ( PFE ) comment in the penultimate paragraph.)

Pfizer ( PFE ) and its supplier Tris Pharma reached a $41.5 million settlement with Texas Attorney General Ken Paxton over allegations they provided adulterated attention deficit hyperactivity disorder medication to children.

The settlement stems from to a November 2023 lawsuit alleging that Pfizer ( PFE ) and Tris Pharma knowingly supplied Quillivant XR to Medicaid patients despite the drug's "pattern of failing quality control tests due to flawed manufacturing practices," Paxton said Wednesday in a statement.

"The settlement relates to historic allegations concerning Quillivant XR, a product that Pfizer ( PFE ) divested and stopped marketing in 2018," a Pfizer ( PFE ) spokesperson said in an emailed statement to MT Newswires. "As part of the settlement agreed to by the state, Pfizer ( PFE ) expressly denies 'any and all liability and wrongdoing.'"

Pfizer ( PFE ) shares fell 2.2% in recent Wednesday trading.

Price: 24.89, Change: -0.56, Percent Change: -2.20